OTOPET THERAPY 10 mg + 200 000 IU/ml ušné kvapky pre mačky a psy
OTOPET THERAPY 10 mg + 200 000 IU/ml ušné kvapky pre mačky a psy
Authorised
- Rifaximin
- COLISTIN SULFATE
- Miconazole
- Triamcinolone acetonide
- CARBARIL
Product identification
Medicine name:
OTOPET THERAPY 10 mg + 200 000 IU/ml ušné kvapky pre mačky a psy
Active substance:
- Rifaximin
- COLISTIN SULFATE
- Miconazole
- Triamcinolone acetonide
- CARBARIL
Target species:
-
Dog
-
Cat
Route of administration:
-
Auricular use
Product details
Active substance and strength:
-
Rifaximin10.00/milligram(s)1.00millilitre(s)
-
COLISTIN SULFATE200000.00/international unit(s)1.00millilitre(s)
-
Miconazole17.40/milligram(s)1.00millilitre(s)
-
Triamcinolone acetonide1.00/milligram(s)1.00millilitre(s)
-
CARBARIL10.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Ear drops, suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QS02CA04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Slovakia
Available in:
-
Slovakia
Package description:
- Available only in Slovak
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Fatro S.p.A.
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
- 96/151/99-S
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Slovak (PDF)
Published on: 19/01/2022